Nebraska Attorney General · October 8, 2026 · Primary source
Attorney General Hilgers Seeks Court Approval for Settlements with Ascend, Citron, and Mayne Over Conspiracy to Inflate Prices and Limit Competition
Summary
Nebraska Attorney General Mike Hilgers joined a 45-state coalition seeking court approval of settlements with Ascend Laboratories, Citron Pharma, and Mayne Pharma over a multi-year conspiracy to artificially inflate prices and suppress competition in the generic prescription drug market. Ascend will pay $400,000 and Mayne will pay $650,000 to the states; Citron, which has ceased operations, agreed only to injunctive terms. The settlements are part of a broader multi-complaint antitrust litigation that has now recovered over $496.5 million from prior settling defendants, with the first trial set for February 2027 in Hartford, Connecticut.
What this may mean
Generic drug manufacturers that engaged in pricing coordination and market allocation conduct between approximately 2009 and 2019 face continued antitrust liability across multiple state complaints, with trial beginning February 2027 for the topical generics complaint covering 80 drugs and 26 corporate defendants. Settling defendants must implement internal antitrust compliance reforms in addition to monetary payments. Pharmaceutical purchasers who bought covered generic drugs during the conspiracy period may be eligible for compensation through the state claims process.
Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.
Related items
- Pennsylvania Attorney General · October 14, 2026Fraud Protection & Consumer Alerts OCT 13, 2026 AG Sunday’s Antitrust Section Takes Action Against Insulin Makers, PBMs for Pricing Scheme, Resulting in Patients Paying More for Life-Saving Meds HARRISBURG, Attorney General Dave Sunday announced a lawsuit against several pharmaceutical companies and pharmacy benefit managers (PBMs) regarding collusion to manipulate insulin price markets, increasing out-of-pocket costs… Read moreScore 85
- Maryland Attorney General · October 2, 2026Attorney General Brown Seeks Court Approval for $400 Million Multistate Settlement with Sandoz over Alleged Conspiracy to Inflate Prices and Limit Competition Published: 10/1/2026Score 85
- Iowa Medicaid Fraud Control Unit · October 3, 2026Attorney General Brenna Bird Seeks Court Approval for $400 Million Settlement with Sandoz for Overcharging for Generic Drugs and Limiting CompetitionScore 80
- Connecticut Attorney General · October 1, 2026Attorney General Tong Seeks Court Approval for $400 Million Settlement With Sandoz Over Conspiracy to Inflate Prices and Limit CompetitionScore 80
- Minnesota Medicaid Fraud Control Unit · September 29, 2026Attorney General Ellison seeks community input on proposed acquisition of Essentia Health by HealthPartnersScore 80
- Nebraska Attorney General · November 1, 2026Attorney General Hilgers Seeks Court Approval for Settlements with Ascend, Citron, and Mayne Over Conspiracy to Inflate Prices and Limit CompetitionScore 75